Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 4/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 4/20 | 0.40 |
| ▸ | CTSS | P25774 | 9/20 | 0.40 |
| ▸ | CTSK | P43235 | 3/20 | 0.40 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.38 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22307805 | 1.00 | PDE3B (0.40) | PDE3BPDE3ACTSSCTSKUTS2R | |
| SCHEMBL22309141 | 0.85 | HPGD (0.46) | PDE3BPDE3ACTSSCTSKXDH | |
| SCHEMBL22308838 | 0.83 | HPGD (0.42) | PDE3BPDE3ACTSSCTSKXDH | |
| SCHEMBL22309158 | 0.80 | PDE3B (0.56) | PDE3BPDE3ACTSSCTSK | |
| SCHEMBL22307812 | 0.79 | PDE3B (0.50) | PDE3BPDE3ACTSSCTSK | |
| SCHEMBL22309142 | 0.79 | XDH (0.49) | PDE3BPDE3AXDH | |
| SCHEMBL22307810 | 0.79 | CTSS (0.46) | PDE3BPDE3ACTSSCTSK | |
| SCHEMBL22309148 | 0.78 | AAK1 (0.44) | PDE3BPDE3A | |
| SCHEMBL22307799 | 0.78 | PDE3B (0.55) | PDE3BPDE3ACTSSCTSKXDH | |
| SCHEMBL22307806 | 0.77 | PDE3B (0.47) | PDE3BPDE3AXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020157189-A1 | 1,2,4-TRIAZIN-6(1H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-08-06 | — | — | WO | disclosed |